LB Research

LB Research

Florence, Italy· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

LB Research is a private, Italy-based Contract Research Organization (CRO) established in 2007, specializing in managing and supporting clinical trials. Its business model is purely service-based, offering expertise across therapeutic areas like oncology and sectors including medical devices and diagnostics. The company appears to be a revenue-generating, small-to-midsize service provider, leveraging its European network to support client research and development programs without developing its own therapeutic products.

Oncology

Technology Platform

Integrated clinical trial service platform offering project management, regulatory affairs, monitoring, data management, and statistical analysis, with specialized expertise in oncology, medical device/diagnostic trials, and community-based studies involving General Practitioners.

Opportunities

Growth in outsourced clinical development, especially in complex oncology trials and post-MDR medical device studies.
Rising demand for real-world evidence and decentralized trials creates an opportunity for their expertise in GP-network studies.

Risk Factors

High competition from large global and regional CROs.
Revenue dependency on a limited client base and vulnerability to downturns in biopharma R&D spending.
Operational risks related to trial execution and regulatory compliance.

Competitive Landscape

Operates in a highly competitive CRO market dominated by large multinational firms (e.g., IQVIA, ICON) and numerous small/mid-sized regional players. Differentiates through specialized focus on medical devices, diagnostics, and Italian/European regulatory expertise, as well as community-based trial execution via GP networks.